Spanish Serial Acquirers: 5 of 13 Earn Above Cost of Capital
[Part of our Global Serial Acquirer Scorecard]
Key Finding: 5 of 13 Spanish serial acquirers earn above 12% ROIC — a 38% Tier A rate that ties with the US. But the best performer, Logista at 32.9% ROIC, runs 2.3% operating margins — the thinnest of any Tier A name across all 14 markets. Zero Tier B companies. Spain is fully polarized: earn above cost of capital, or destroy it.
We screened 13 Spanish serial acquirers listed on BME by return on invested capital. Five earn above a 12% cost of equity. Three earn between 5% and 10%. Five destroy value below 5% ROIC — including one posting negative returns. Zero sit at the borderline. The same polarization we see in Australia: no Tier B.
The Spanish Serial Acquirer Scorecard
| # | Company | Ticker | ROIC | GW/TA | (GW+Int)/TA | Op Margin | Drawdown | Tier | Verdict |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Logista | LOG | 32.9% | 12% | 58% | 2.3% | -18.0% | A | Asset-light distribution monopoly. Extreme capital efficiency. |
| 2 | Vidrala | VID | 17.4% | 11% | 51% | 21.2% | -42.0% | A | Glass packaging consolidator. Genuine pricing power. |
| 3 | Viscofan | VIS | 13.6% | 1% | 29% | 16.8% | -23.0% | A | Organic grower, minimal M&A. Near-zero goodwill. |
| 4 | Puig | PUIG | 12.8% | 25% | 55% | 15.6% | -51.0% | A | Luxury brand acquirer. Newly listed. |
| 5 | Indra | IDR | 12.8% | 21% | 26% | 9.2% | -31.0% | A | Defense/IT modernizer. |
| 6 | CIE Auto | CIE | 7.3% | 31% | 15% | 13.6% | -33.0% | C | Auto parts rollup. Decent margins, diluted ROIC. |
| 7 | Ebro Foods | EBRO | 7.2% | 20% | 15% | 9.7% | -14.0% | C | Stable food, mediocre returns. |
| 8 | CAF | CAF | 6.0% | 4% | 17% | 5.1% | -44.0% | C | Rail infrastructure. Low margins. |
| 9 | Fluidra | FDR | 4.8% | 37% | 2% | 12.5% | -67.0% | D | Pool equipment. Zodiac deal destroyed returns. |
| 10 | Prosegur | PSG | 2.9% | 16% | 61% | 6.2% | -49.0% | D | Security conglomerate. Low returns. |
| 11 | Grifols | GRF | 0.8% | 35% | 31% | 16.0% | -72.0% | D | Plasma acquirer drowning in debt. |
| 12 | Almirall | ALM | 0.5% | 13% | 42% | 4.7% | -49.0% | D | Pharma pivot to derm. Value destruction. |
| 13 | Cellnex | CLNX | -0.1% | 15% | 26% | 14.3% | -59.0% | D | Tower rollup. Negative ROIC despite 14% margins. |
Tier A: 5 companies (38%). Tier B: 0 (0%). Tier C: 3 (23%). Tier D: 5 (38%).
The 38% Tier A rate matches the US. But five Tier D names drag the average — all earning below 5% ROIC, one posting negative returns. Zero Tier B means the same polarization as Australia: no borderline cases, no company sitting on the edge.
The Goodwill Cliff
The pattern holds in Spain. Every company with GW/TA above 30% earns below cost of capital.
| GW/TA > 30% | ROIC | Op Margin | Above CoC? |
|---|---|---|---|
| Fluidra (37%) | 4.8% | 12.5% | No |
| Grifols (35%) | 0.8% | 16.0% | No |
| CIE Auto (31%) | 7.3% | 13.6% | No |
0 of 3 earn above cost of capital. Grifols runs 16.0% operating margins — impressive for pharma — but the goodwill-laden balance sheet absorbs every margin point. CIE Automotive posts 13.6% margins, decent for auto parts, yet delivers only 7.3% ROIC. The denominator wins.
Five That Work
Logista — 32.9% ROIC with 12% GW/TA and 2.3% operating margins. The capital efficiency paradox: the best ROIC in Spain comes from the company with the thinnest margins of any Tier A name across all 14 markets. Logista is an asset-light tobacco and pharma distribution monopoly. It doesn’t need high margins because it barely ties up capital. A 58% (GW+Int)/TA ratio looks alarming until you realize the total asset base is small relative to throughput. Down only 18.0%. Proof that ROIC is about capital efficiency, not margin levels.
Vidrala — 17.4% ROIC with 11% GW/TA and 21.2% operating margins. Glass container consolidator with genuine pricing power. The best risk/reward profile in Spain: high ROIC, low goodwill, moderate drawdown at -42.0%. Family-controlled (Delclaux family), which correlates with capital discipline across the Spanish sample.
Viscofan — 13.6% ROIC with 1% GW/TA and 16.8% operating margins. Barely a serial acquirer. Viscofan grows organically in artificial casings for processed meat. Near-zero goodwill means almost no acquisition premium in the denominator. Down 23.0%. The OEM-B of Spain — discipline through restraint.
Puig — 12.8% ROIC with 25% GW/TA and 15.6% operating margins. Luxury brand acquirer, newly listed in 2024. Limited track record as a public company. Down 51.0% — a deep drawdown for a name still earning above cost of capital. If the brand portfolio holds, the drawdown is opportunity. But “newly listed” and “limited track record” deserve weight.
Indra — 12.8% ROIC with 21% GW/TA and 9.2% operating margins. Defense and IT modernizer. Not a classic serial acquirer — more a government contractor that has grown through targeted acquisitions. Down 31.0%. The 26% (GW+Int)/TA is manageable. ROIC improved from 5% to 13% over five years — one of the strongest improving trajectories in any market.
How the Rest Fail
Auto Parts and Food: Tier C Mediocrity
CIE Automotive — 7.3% ROIC with 31% GW/TA and 13.6% operating margins. Auto parts rollup with decent operations that cannot service the goodwill base. LatAm expansion diluted returns further. Down 33.0%.
Ebro Foods — 7.2% ROIC with 20% GW/TA and 9.7% operating margins. Stable food business, stable mediocrity. Down 14.0% — the market barely punishes it because expectations were never high.
CAF — 6.0% ROIC with 4% GW/TA and 5.1% operating margins. Rail infrastructure with low margins and low goodwill. CAF’s problem is not acquisition excess — the margins are simply too thin for the capital deployed. Down 44.0%.
One-Deal Destroyer: Fluidra
Fluidra — 4.8% ROIC with 37% GW/TA and 12.5% operating margins. The Zodiac Pool merger in 2018 compressed ROIC permanently. GW/TA jumped to 37%. Margins of 12.5% are too thin for the goodwill burden. Down 67.0% — the deepest drawdown in the Spanish universe after Grifols.
Debt Spiral: Grifols
Grifols — 0.8% ROIC with 35% GW/TA and 16.0% operating margins. Plasma collection rollup drowning in debt. The Talecris acquisition in 2011 was the inflection point — it loaded the balance sheet and started the debt-fueled acquisition treadmill. Operating margins of 16.0% are impressive for pharma but insufficient on the bloated balance sheet. Short seller reports added pressure. Down 72.0% — the worst drawdown in Spain.
Commodity Security: Prosegur
Prosegur — 2.9% ROIC with 16% GW/TA and 6.2% operating margins. Security services is inherently low-margin, low-moat. LatAm expansion diluted returns further. Down 49.0%.
Pharma Pivot: Almirall
Almirall — 0.5% ROIC with 13% GW/TA and 4.7% operating margins. Pivoted from generics to dermatology via acquisitions. The acquired portfolios did not generate adequate returns. Down 49.0%.
Tower Rollup: Cellnex
Cellnex — negative 0.1% ROIC with 15% GW/TA and 14.3% operating margins. Tower infrastructure rollup financed by debt and equity dilution. The margins look healthy but cannot service the capital deployed. Classic case where good operating metrics mask terrible capital returns. Down 59.0%.
The Logista Paradox
Logista is the standout because it breaks the intuition. High-ROIC serial acquirers across our 14-market screen typically earn above cost of capital through fat operating margins. Logista does it with 2.3%.
The explanation is capital turnover. Mauboussin & Callahan (2023) decompose ROIC into NOPAT margin multiplied by invested capital turnover — two paths to the same destination. Logista takes the turnover path: minimal fixed assets, minimal working capital, massive throughput. The asset base is tiny relative to revenue.
This makes Logista the purest illustration of the two-path ROIC decomposition in our entire universe. High-margin/low-turnover names like Vidrala (21.2% margins) and low-margin/high-turnover names like Logista (2.3% margins) can reach the same Tier A destination through opposite strategies.
The Cautionary Tale: Grifols and the Debt Treadmill
Pre-Talecris, Grifols was a healthy mid-cap plasma company. The 2011 Talecris acquisition loaded the balance sheet. From there, each subsequent deal required more debt to finance, and each debt load required more acquisitions to service — the classic debt treadmill. Today: 0.8% ROIC, 35% GW/TA, -72.0% drawdown, and short sellers circling.
The same pattern destroyed Fluidra. The 2018 Zodiac merger tripled goodwill. ROIC never recovered. One deal is all it takes.
Cross-Market Context
| Metric | Spain (13) | US (16) | Germany (10) | Sweden (24) |
|---|---|---|---|---|
| Above 12% ROIC | 5 (38%) | 6 (38%) | 3 (30%) | 6 (25%) |
| Below 5% ROIC | 5 (38%) | 0 (0%) | 6 (60%) | 9 (38%) |
| Avg GW/TA | 18% | 43% | 27% | 34% |
| Avg Op Margin | 10.3% | 22.4% | 10.2% | 8.8% |
| Worst drawdown | -72.0% GRF | -55.6% TYL | -63.3% BKHT | -61.8% VIT-B |
Spain matches the US at 38% Tier A. But the US has zero companies below 5% ROIC, while Spain has five. Germany has the opposite problem: only 30% Tier A but 60% Tier D.
Spain’s average GW/TA of 18% ranks among the lowest of any market screened — only Japan (11.5%) and Switzerland (17%) are lower. Low aggregate goodwill with a strong Tier A rate suggests the Spanish winners rely more on capital efficiency than acquisition volume. That matches the data: Logista at 12% GW/TA, Viscofan at 1%, Vidrala at 11%.
The Swedish model — 24 public serial acquirers competing for targets — has no analogue in Spain. Spain’s acquirers operate in distinct industries (distribution, glass, pharma, defense) without the crowded roll-up dynamics that compress Swedish ROIC.
Spain-Specific: No Software Serial Acquirer
Spain has no Constellation Software, no Dassault, no Constellation equivalent. The closest is Indra (defense/IT), but that is a government contractor, not a VMS acquirer. This gap means Spain lacks the acquisition model that produces the highest ROIC globally. The winners here — Logista, Vidrala, Viscofan — win through operational excellence and capital efficiency, not through acquisition playbooks.
Unlike Italy, where 55% of acquirers stagnate in Tier C, Spain’s winners rely on operational excellence rather than acquisition playbooks. Family ownership reinforces the discipline. Vidrala (Delclaux family) and Viscofan (Echevarría family) — the two most disciplined names — are family-controlled. Concentrated ownership correlates with capital discipline in the Spanish sample.
What to Look For in Spanish Serial Acquirers
Four filters for this market:
- Separate margin from ROIC. Logista proves that 2.3% margins can produce 32.9% ROIC. Cellnex proves that 14.3% margins can produce -0.1% ROIC. In Spain, operating margins tell you nothing about capital returns without the denominator.
- Watch the LatAm expansion. Prosegur, CIE Automotive, and Grifols all expanded into Latin America. Currency risk, political instability, and weaker contract enforcement consistently diluted returns. LatAm revenue is a yellow flag for Spanish acquirers.
- Check ROIC trend direction. Indra improved from 5% to 13% over five years. Fluidra declined from 10% to 5%. The direction matters more than the level — Mauboussin & Callahan (2023) found that bottom-to-top quintile ROIC transitions produce 33% compound annual TSR.
- Demand family or founder discipline. Vidrala and Viscofan — both family-controlled — earn the most consistent returns. Grifols was also family-controlled but lost discipline when acquisition scale exceeded family oversight. Family ownership is necessary but not sufficient.
Methodology
We screened 13 Spanish serial acquirers listed on BME. All financial data in EUR.
- ROIC: Net operating profit after tax / invested capital (equity + debt - cash), with goodwill included in the denominator. Source: QuickFS (latest fiscal year, exchange code: BME).
- GW/TA: Goodwill / total assets (most recent quarter). Source: QuickFS.
- (GW+Int)/TA: Combined goodwill and identifiable intangible assets / total assets. Source: QuickFS.
- Operating margin: Operating income / revenue (latest fiscal year). Source: QuickFS.
- Drawdown: Maximum decline from 5-year peak. Source: Yahoo Finance (.MC suffix).
- Tier classification: A (>12%), B (10-12%), C (5-10%), D (<5%).
- Data as of: February 2026.
Puig (PUIG) was newly listed in 2024 and has a limited track record as a public company. Viscofan is primarily an organic grower but is included because it is frequently grouped with Spanish serial acquirers. Mauboussin & Callahan (2023) provide the ROIC decomposition framework referenced in the Logista analysis.1
Mauboussin, M.J. & Callahan, D. (2023). “ROIC and the Investment Process.” Morgan Stanley Counterpoint Global. Median ROIC of 9.5% for Russell 3000 (1990-2022). ROIC = NOPAT margin x IC turnover (Exhibit 13, p.11). ↩︎